Effect of a 5-Day Regimen on Peripheral Stem Cell Mobilization
- Study Title
- Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Participants
- Teva Identifier
- TV44688-ONC-30054
- ClinicalTrials.gov Identifier
- NCT03029000
- Study Status
- Terminated
- Trial Condition(s)
- Healthy Participants
- Interventions
- Drug: Tbo-filgrastim
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 60 Years
- Trial Duration
- August 2, 2017 - October 30, 2017
- Phase
- Phase 3
